In good news for those averse to injections, GLP-1 agonist medication is a step closer to being offered in oral pill form, ...
sold as Wegovy and Zepbound for weight loss (and for diabetes as the better-known Ozempic and Mounjaro). Dushay cited hopes ...
AstraZeneca said on Monday its experimental weight-loss pill, licensed from China's Eccogene, was safe and tolerable in an ...
Viking Therapeutics (VKTX) shares are taking a dive in Monday's session despite on rising manufacturing concerns and ...
Wegovy® is the only version of semaglutide that is FDA-approved for weight loss, while Ozempic® and other forms of the drug ...
Viking Therapeutics Inc. cheered analysts Monday after the biotech posted data on its oral weight-loss drug showing ...
Data from the Phase 1 trial now under way has already yielded ... and Eli Lilly & Co. (LLY), are working to develop a weight-loss pill. Jefferies is confident Viking's stock still has plenty ...
Only 13 states currently allow Medicaid to cover treatment of obesity using glucagon-like peptide-1 agonist (GLP-1) medications, researchers said.